DANCANN PHARMA

dancann-pharma-logo

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.

#People #Event #Website #More

DANCANN PHARMA

Social Links:

Industry:
Biotechnology Manufacturing Medical Pharmaceutical Therapeutics

Founded:
2018-01-01

Address:
Ansager, Syddanmark, Denmark

Country:
Denmark

Website Url:
http://www.dancann.com

Status:
Active

Contact:
45 6916 0393

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS YouTube


Current Employees Featured

sarah-mai-lykke-kjeldsen_image

Sarah Mai Lykke-Kjeldsen
Sarah Mai Lykke-Kjeldsen COO @ Dancann Pharma
COO
2022-01-01

martin-vedel-ernst_image

Martin Vedel Ernst
Martin Vedel Ernst Chief Financial Officer @ Dancann Pharma
Chief Financial Officer
2022-05-01

louise-conradsen_image

Louise Conradsen
Louise Conradsen Chief Executive Officer @ Dancann Pharma
Chief Executive Officer
2022-01-01

Official Site Inspections

http://www.dancann.com Semrush global rank: 9.28 M Semrush visits lastest month: 182

  • Host name: 76.76.21.21
  • IP address: 76.76.21.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Dancann Pharma"

About - dancann.com

At DanCann Pharma, Peter Søndergaard will lead the finance function in the growing organization, which consists of DanCann Pharma A/S and the subsidiary CannGros ApS.See details»

Home [www.dancann.com]

The term for formulated, processed or synthetic cannabis sold as a finished product which has undergone full medical trials, and holds a medical marketing authorization.See details»

Investor Relations - dancann.com

DanCann Pharma is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. DanCann Pharma was โ€ฆSee details»

DanCann Pharma A/S: A strong and growing organization is ready โ€ฆ

DanCann Pharma A/S: A strong and growing organization is ready to fulfill the commercial ambitions COPENHAGEN, Denmark, November 10, 2022 - DanCann Pharma A/S (SS: โ€ฆSee details»

Dancann Pharma - Crunchbase Company Profile & Funding

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.See details»

DanCann Pharma Company Description - Stock Analysis

Nov 28, 2024 Company profile for DanCann Pharma A/S (NGM: DANCAN) with a description, list of executives, contact details and other key facts.See details»

Dancann Pharma - Funding, Financials, Valuation & Investors

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.See details»

DanCann Pharma DanCann Pharma's CEO: Building organization โ€ฆ

May 6, 2022 DanCann Pharma was founded in 2018 and has since taken huge strides towards establishing itself as a manufacturer and distributor of products in the medical cannabis โ€ฆSee details»

DanCann Pharma: DanCann Pharma A/S - MarketScreener

6 days ago DanCann Pharma is represented through its membership in the Medicinsk Cannabis Industri (MCI), where the Company's CEO, Jeppe Krog Rasmussen, serves as Vice Chairman โ€ฆSee details»

DanCann Pharma A/S (DANCAN.ST) - Yahoo Finance Canada

Find the latest DanCann Pharma A/S (DANCAN.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

DanCann Pharma A/S: A strong and growing organization is ready โ€ฆ

Nov 10, 2022 COPENHAGEN, Denmark, November 10, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by โ€ฆSee details»

DanCann Pharma A/S: A strengthened market position after an โ€ฆ

DanCann Pharma is looking into a new reality, now that both capital increase, EU-GMP certification and share listing in the USA have been ticked off. The DanCann Pharma CEO is โ€ฆSee details»

DanCann Pharma A/S: Agreement Reached on Permanent โ€ฆ

6 days ago To ensure continued collaboration and knowledge sharing, the reference group for medicinal cannabis will be extended through 2025 and 2026. DanCann Pharma is represented โ€ฆSee details»

DanCann Pharma A/S: A strong and growing organization is ready โ€ฆ

Nov 10, 2022 COPENHAGEN, Denmark, November 10, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the โ€œCompanyโ€), a Danish company powered by โ€ฆSee details»

DanCann Pharma A/S strengthening the organization with new โ€ฆ

DanCann Pharma is a vertically integrated, licensed production and distribution Company. The Company focuses on discovering, developing, manufacturing, and commercializing new โ€ฆSee details»

Investor Relations - dancann.com

At DanCann Pharma, Peter Søndergaard will lead the finance function in the growing organization, which consists of DanCann Pharma A/S and the subsidiary CannGros ApS.See details»

DanCann Pharma's CEO: Building organization and strong results โ€ฆ

May 6, 2022 DanCann Pharma was founded in 2018 and has since taken huge strides towards establishing itself as a manufacturer and distributor of products in the medical cannabis โ€ฆSee details»

Patient - dancann.com

Pharmaceutical Cannabis The term for formulated, processed or synthetic cannabis sold as a finished product which has undergone full medical trials, and holds a medical marketing โ€ฆSee details»

Medical Cannabis - dancann.com

Pharmaceutical cannabis means the term for formulated, processed or synthetic cannabis sold as a finished product, which has undergone full medical trials, and holds (in one or more โ€ฆSee details»

Investor Relations - dancann.com

Introduction Share Information Press Releases Initial Public Offering (IPO) General Meetings Corporate Governance Financial Calendar Financial Reports IR-Contact Board of Directors โ€ฆSee details»